Division 1 THE BLOOD COMPONENTS
United Kingdom
| 1. Red cell preparations | The components listed in points 1.1 to 1.8 may be further processed within blood establishments and must be labelled accordingly |
| 1.1 | Red cells |
| 1.2 | Red cells, buffy coat removed |
| 1.3 | Red cells, leucocyte-depleted |
| 1.4 | Red cells, in additive solution |
| 1.5 | Red cells, buffy coat removed, in additive solution |
| 1.6 | Red cells, leucocyte-depleted, in additive solution |
| 1.7 | Red cells, apheresis |
| 1.8 | Whole blood |
| 2. Platelet preparations | The components listed in points 2.1 to 2.6 may be further processed within blood establishments and must be labelled accordingly |
| 2.1 | Platelets, apheresis |
| 2.2 | Platelets, apheresis, leucocyte-depleted |
| 2.3 | Platelets, recovered, pooled |
| 2.4 | Platelets, recovered, pooled, leucocyte-depleted |
| 2.5 | Platelets, recovered, single unit |
| 2.6 | Platelets, recovered, single unit, leucocyte-depleted |
| 3. Plasma preparations | The components listed in 3.1 to 3.3 may be further processed within blood establishments and must be labelled accordingly. |
| 3.1 | Fresh-frozen plasma |
| 3.2 | Fresh-frozen plasma, cryoprecipitate-depleted |
| 3.3 | Cryoprecipitate |
| 4. | Granulocytes, apheresis |
| 5. New components | Quality and safety requirements for new blood components must be regulated by the competent national authority. Such new components must be notified to the European Commission with a view to Community action |